Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Thota RR"'
Autor:
Miller AM; Center for Cancer Immunotherapy, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.; Division of Hematology and Oncology, UCSD Moores Cancer Center, 3855 Health Sciences Drive, La Jolla, CA 92093, USA., Koşaloğlu-Yalçın Z; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA., Westernberg L; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA., Montero L; Center for Cancer Immunotherapy, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA., Bahmanof M; Center for Cancer Immunotherapy, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA., Frentzen A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA., Lanka M; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA., Logandha Ramamoorthy Premlal A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA., Seumois G; Center for Cancer Immunotherapy, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA., Greenbaum J; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA., Brightman SE; Center for Cancer Immunotherapy, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA., Soria Zavala K; Center for Cancer Immunotherapy, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA., Thota RR; Center for Cancer Immunotherapy, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA., Naradikian MS; Center for Cancer Immunotherapy, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA., Makani SS; Division of Hematology and Oncology, UCSD Moores Cancer Center, 3855 Health Sciences Drive, La Jolla, CA 92093, USA., Lippman SM; Division of Hematology and Oncology, UCSD Moores Cancer Center, 3855 Health Sciences Drive, La Jolla, CA 92093, USA., Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA., Cohen EEW; Division of Hematology and Oncology, UCSD Moores Cancer Center, 3855 Health Sciences Drive, La Jolla, CA 92093, USA., Peters B; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.; Department of Medicine, University of California, San Diego (UCSD), La Jolla, CA 92037, USA., Schoenberger SP; Center for Cancer Immunotherapy, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.; Division of Hematology and Oncology, UCSD Moores Cancer Center, 3855 Health Sciences Drive, La Jolla, CA 92093, USA.
Publikováno v:
Science translational medicine [Sci Transl Med] 2024 Feb 28; Vol. 16 (736), pp. eabj9905. Date of Electronic Publication: 2024 Feb 28.
Autor:
Dolina JS; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, California, USA.; Cancer Immunology Discovery, Pfizer, San Diego, California, USA., Lee J; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, California, USA., Brightman SE; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, California, USA., McArdle S; Imaging Facility and., Hall SM; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, California, USA., Thota RR; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, California, USA., Zavala KS; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, California, USA., Lanka M; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, California, USA., Ramamoorthy Premlal AL; Bioinformatics Core, La Jolla Institute for Immunology, La Jolla, California, USA., Greenbaum JA; Bioinformatics Core, La Jolla Institute for Immunology, La Jolla, California, USA., Cohen EEW; Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, California, USA., Peters B; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, California, USA.; Department of Medicine, University of California San Diego, La Jolla, California, USA., Schoenberger SP; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, California, USA.; Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, La Jolla, California, USA.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2023 Sep 01; Vol. 133 (17). Date of Electronic Publication: 2023 Sep 01.
Autor:
Brightman SE; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA.; Biomedical Sciences Program, School of Medicine, University of California San Diego, La Jolla, CA, USA., Becker A; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA., Thota RR; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA., Naradikian MS; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA., Chihab L; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA, USA., Zavala KS; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA., Ramamoorthy Premlal AL; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA, USA., Griswold RQ; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA.; Biomedical Sciences Program, School of Medicine, University of California San Diego, La Jolla, CA, USA., Dolina JS; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA., Cohen EEW; Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, UCSD, La Jolla, CA, USA., Miller AM; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA.; Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, UCSD, La Jolla, CA, USA., Peters B; Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, UCSD, La Jolla, CA, USA.; Department of Medicine, University of California San Diego, La Jolla, CA, USA., Schoenberger SP; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA. sps@lji.org.
Publikováno v:
Nature immunology [Nat Immunol] 2023 Aug; Vol. 24 (8), pp. 1345-1357. Date of Electronic Publication: 2023 Jul 03.
Autor:
Brightman SE; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA.; Biomedical Sciences Program, School of Medicine, University of California San Diego, La Jolla, CA, USA., Becker A; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA., Thota RR; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA., Naradikian MS; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA., Chihab L; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA, USA., Zavala KS; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA., Ramamoorthy Premlal AL; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA, USA., Griswold RQ; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA.; Biomedical Sciences Program, School of Medicine, University of California San Diego, La Jolla, CA, USA., Dolina JS; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA., Cohen EEW; Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, UCSD, La Jolla, CA, USA., Miller AM; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA.; Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, UCSD, La Jolla, CA, USA., Peters B; Division of Hematology and Oncology, University of California San Diego Moores Cancer Center, UCSD, La Jolla, CA, USA.; Department of Medicine, University of California San Diego, La Jolla, CA, USA., Schoenberger SP; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA. sps@lji.org.
Publikováno v:
Nature immunology [Nat Immunol] 2023 Aug; Vol. 24 (8), pp. 1391.
Autor:
Dolina JS, Lee J, Brightman SE, McArdle S, Hall SM, Thota RR, Lanka M, Premlal ALR, Greenbaum JA, Cohen EEW, Peters B, Schoenberger SP
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 May 07. Date of Electronic Publication: 2023 May 07.
Autor:
Brightman SE; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, California, USA.; Biomedical Sciences Program, School of Medicine, UCSD, La Jolla, California, USA., Naradikian MS; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, California, USA.; Division of Hematology and Oncology, UCSD Moores Cancer Center, La Jolla, California, USA.; Novartis, San Diego, California, USA., Thota RR; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, California, USA., Becker A; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, California, USA.; IconOVir Bio, San Diego, California, USA., Montero L; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, California, USA., Bahmanof M; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, California, USA., Premlal ALR; Bioinformatics Core and., Greenbaum JA; Bioinformatics Core and., Peters B; Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, California, USA.; Department of Medicine, UCSD, La Jolla, California, USA., Cohen EE; Division of Hematology and Oncology, UCSD Moores Cancer Center, La Jolla, California, USA., Miller AM; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, California, USA.; Division of Hematology and Oncology, UCSD Moores Cancer Center, La Jolla, California, USA., Schoenberger SP; Division of Developmental Immunology, La Jolla Institute for Immunology, La Jolla, California, USA.
Publikováno v:
JCI insight [JCI Insight] 2023 Jan 24; Vol. 8 (2). Date of Electronic Publication: 2023 Jan 24.